Trials / Unknown
UnknownNCT05484700
Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms
SARS-CoV-2 Neutralizing Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Correlation With Immunity and Long-COVID-19 Symptoms
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 305 (estimated)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
We investigated the association between immune system responsibilities in Long COVID patients and Full recovery patients.
Detailed description
This retrospective cohort study compared immunogenicity post COVID-19 between individuals (aged 18-65 years and had confirmed SARS-CoV-2 infection from January to May 2022 ) with residual Long COVID-19 symptoms (LC) and ones with full recovery (Full) related to pathophysiology, immunology and clinical consequence.
Conditions
Timeline
- Start date
- 2021-12-30
- Primary completion
- 2022-07-25
- Completion
- 2022-12-29
- First posted
- 2022-08-02
- Last updated
- 2022-08-05
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT05484700. Inclusion in this directory is not an endorsement.